Abstract
Despite the utility of antiangiogenic drugs in ovarian cancer, efficacy remains limited due to resistance linked to alternate angiogenic pathways and metastasis. Therefore, we investigated PG545, an anti-angiogenic and anti-metastatic agent which is currently in Phase I clinical trials, using preclinical models of ovarian cancer. PG545's anti-cancer activity was investigated in vitro and in vivo as a single agent, and in combination with paclitaxel, cisplatin or carboplatin using various ovarian cancer cell lines and tumour models. PG545, alone, or in combination with chemotherapeutics, inhibited proliferation of ovarian cancer cells, demonstrating synergy with paclitaxel in A2780 cells. PG545 inhibited growth factor-mediated cell migration and reduced HB-EGF-induced phosphorylation of ERK, AKT and EGFR in vitro and significantly reduced tumour burden which was enhanced when combined with paclitaxel in an A2780 model or carboplatin in a SKOV-3 model. Moreover, in the immunocompetent ID8 model, PG545 also significantly reduced ascites in vivo. In the A2780 maintenance model, PG545 initiated with, and following paclitaxel and cisplatin treatment, significantly improved overall survival. PG545 increased plasma VEGF levels (and oth...Continue Reading
References
Apr 7, 2000·Carcinogenesis·K F RobyP F Terranova
Mar 16, 2001·Biochimica Et Biophysica Acta·C R ParishM D Hulett
Apr 9, 2001·Seminars in Cell & Developmental Biology·R D Sanderson
Jul 3, 2002·Nature Reviews. Cancer·Ram SasisekharanUma Narayanasami
Nov 10, 2004·Matrix Biology : Journal of the International Society for Matrix Biology·Ralph D SandersonThomas Kelly
Jul 8, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Yoshihiro TanakaHitoo Nakano
Nov 1, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Christopher G WillettGregory Y Lauwers
Feb 3, 2006·Cancer Research·Anna ZetserNeta Ilan
Jun 13, 2006·The Journal of Clinical Investigation·Jeremy ChienViji Shridhar
Jun 23, 2006·Annals of Oncology : Official Journal of the European Society for Medical Oncology·O PichelmayerM Raderer
Sep 14, 2006·Pharmacological Reviews·Ting-Chao Chou
Oct 13, 2006·Gynecologic Oncology·Ben DavidsonReuven Reich
Sep 9, 2008·Oncology Research·Gang ChenXiao-Ling Tang
Sep 24, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Shuji MikamiYasunori Okada
Dec 3, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Seiji MabuchiMasahide Ohmichi
Dec 3, 2008·International Journal of Cancer. Journal International Du Cancer·Hiroshi YagiShingo Miyamoto
Apr 10, 2009·Investigational New Drugs·K DredgeI Bytheway
Dec 17, 2009·The Oncologist·Sebastian KoboldDjordje Atanackovic
Feb 11, 2011·Cancer Metastasis Reviews·Gil ArvatzIsrael Vlodavsky
Sep 16, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Shingo MiyamotoEisuke Mekada
Feb 22, 2012·Clinical Obstetrics and Gynecology·Michael A Bookman
Mar 31, 2012·Journal of Medicinal Chemistry·Vito FerroIan Bytheway
Apr 21, 2012·Drugs·Sohita Dhillon
Apr 25, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Carol AghajanianLawrence R Nycum
May 18, 2012·Current Pharmaceutical Design·Arne R M van der BiltAnna K L Reyners
May 23, 2012·Biochemical and Biophysical Research Communications·Xiao-han TangMei-song Lu
Sep 20, 2012·Journal of Ovarian Research·Christine Vestergaard MadsenAnders Jakobsen
Feb 5, 2013·The FEBS Journal·Vishnu C RamaniRalph D Sanderson
May 23, 2013·Molecular Cancer Therapeutics·Katherine T OstapoffRolf A Brekken
Aug 2, 2013·International Journal of Molecular Sciences·Nikos G GavalasAristotle Bamias
Oct 5, 2013·Frontiers in Oncology·Nuzhat Ahmed, Kaye L Stenvers
Nov 20, 2013·FEBS Open Bio·Edward HammondIan Bytheway
Feb 25, 2014·The Journal of Biological Chemistry·Claire L ColeEgle Avizienyte
Feb 26, 2014·Frontiers in Oncology·Honami Naora
Jun 28, 2014·Cancer Research·Ilanit BoyangoIsrael Vlodavsky
Jan 15, 2015·Cancer Biomarkers : Section a of Disease Markers·Haiyan ZhengJianqiao Liu
Citations
Apr 9, 2016·Future Medicinal Chemistry·Silvia RivaraGiuseppe Giannini
Oct 28, 2016·Cancer Chemotherapy and Pharmacology·Cong WangHongmin Liu
Oct 27, 2016·Experimental Hematology·Benjamin Heyman, Yiping Yang
Feb 9, 2017·Scientific Reports·Debarshi RoyViji Shridhar
Jun 28, 2017·Organic & Biomolecular Chemistry·Ryan J WeissYitzhak Tor
Mar 14, 2018·British Journal of Cancer·Keith DredgeMichael Millward
Oct 5, 2017·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Ling-Yan JiaYi Charlie Chen
Dec 9, 2015·Antimicrobial Agents and Chemotherapy·Joanna S SaidTomas Bergström
May 22, 2019·Frontiers in Oncology·Alyce J MayfoshMark D Hulett
May 4, 2018·Oncotarget·Amit KatzIsrael Vlodavsky
Jul 5, 2016·Oncotarget·Giuliana CassinelliCinzia Lanzi
Dec 2, 2015·Oncotarget·Vishnu C RamaniRalph D Sanderson
Nov 30, 2018·Cells·Valentina MasolaMaurizio Onisto
Nov 22, 2016·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Sid E O'BryantUNKNOWN Biofluid Based Biomarker Professional Interest Area
Jun 1, 2017·Molecular Medicine Reports·Yi ZhangGan-Lin Zhang
Mar 3, 2020·Frontiers in Immunology·Ievgen O KoliesnikPaul L Bollyky
Sep 18, 2015·Oncotarget·Susmita MondalViji Shridhar
Jun 15, 2018·Journal for Immunotherapy of Cancer·Edward HammondKeith Dredge
Nov 11, 2018·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Cinzia Lanzi, Giuliana Cassinelli
Feb 14, 2018·Antimicrobial Agents and Chemotherapy·Aroon SupramaniamLara J Herrero
Oct 13, 2016·Annual Review of Pharmacology and Toxicology·Shawn M Davidson, Matthew G Vander Heiden
Nov 22, 2017·Molecular Cancer Therapeutics·Anindya DeyResham Bhattacharya
Jan 6, 2021·Biomolecules·Jooho ParkHyung-Sik Won
May 20, 2019·IScience·Chakrabhavi Dhananjaya MohanKanchugarakoppal S Rangappa
Jun 13, 2017·Cancer Letters·Hua SuiQi Li
Mar 17, 2021·Journal of Experimental & Clinical Cancer Research : CR·Haoze LiQing Ji